Table 1.
Baseline Demographics and Presenting Symptoms of Patients Included in This Cohort of 44 Hemodialysis Patients Tested for Influenza Between November 1, 2017 and March 31, 2018, Stratified by Testing Platform.
Variable | Rapid PCR (n = 14) | Standard of care PCR (n = 30) | P-value |
---|---|---|---|
Age—years (mean [SD]) | 71.0 (10.8) | 67.6 (15.1) | .61 |
Sex (%) | 1.00 | ||
Female | 5 (35.7) | 12 (40.0) | |
Male | 9 (64.3) | 18 (60.0) | |
Duration of dialysis therapy—years (mean [SD]) |
3.64 (3.12) | 3.32 (3.61) | .84 |
Cause of end-stage kidney disease (%) | .49 | ||
Hypertension | 2 (14.3) | 3 (10.0) | |
Diabetes | 3 (21.4) | 13 (43.3) | |
Glomerulonephritis | 5 (35.7) | 5 (16.7) | |
Other | 4 (28.6) | 4 (13.3) | |
Influenza vaccination in past year (%) | .54 | ||
Yes | 13 (92.9) | 29 (96.7) | |
No | 1 (7.1) | 1 (3.3) | |
Symptoms present at presentation (%) | |||
Cough | 13 (92.9) | 20 (66.7) | .08 |
Fever | 1 (7.1) | 7 (23.3) | .40 |
Shortness of breath | 3 (21.4) | 8 (26.7) | 1.0 |
Malaise | 2 (14.3) | 5 (16.7) | 1.0 |
Other symptomsa | 1 (7.1) | 5 (16.7) | .65 |
Note. PCR = polymerase chain reaction; SD = standard deviation.
Other symptoms reported included nasal discharge, rigors, wheeze, and sore throat.